UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 11, 2015

 

APPLIED GENETIC TECHNOLOGIES CORPORATION

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

 

001-36370

 

59-3553710

(State or Other Jurisdiction

of Incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

 

 

 

 

11801 Research Drive

Suite D

Alachua, Florida

 

 

 

32615

(Address of Principal Executive Offices)

 

 

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (386) 462-2204  

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 


 

Item 2.02     Results of Operations and Financial Condition

On February 11, 2015, Applied Genetic Technologies Corporation issued a press release entitled “AGTC Announces Financial Results for the Second Quarter Ended December 31, 2014.”  The earnings release is furnished as Exhibit 99.1.

Item 9.01     Financial Statements and Exhibits.

(c)

 

Exhibit

No.

 

Description 

 

99.1

 

 

Press release dated February 11, 2015, entitled “AGTC Announces Financial Results for the Second Quarter Ended December 31, 2014

 

 

 

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

APPLIED GENETIC TECHNOLOGIES CORPORATION

 

 

 

 

 

Date:   February 11, 2015

 

By:

/s/ Lawrence E. Bullock

 

 

 

 

Lawrence E. Bullock

 

 

 

 

Chief Financial Officer

 

 

 

 

3


 

EXHIBIT INDEX

 

Exhibit

No.

 

Description 

 

99.1

 

 

Press release dated February 11, 2015, entitled “AGTC Announces Financial Results for the Second Quarter Ended December 31, 2014

 

 

4